Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

BosomShield A comprehensive CAD system based on radiologic- and pathologic-image biomarkers for diagnosis and prognosis of breast cancer relapse

Coordinator
Universitat Rovira I Virgili, Spain
Runs
1 September 2022 to 31 August 2026
Status
Running
EU funding
€2.6m
Total cost
—
Partners
25 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101073222

What the project is doing

In the project's own words, from its summary on CORDIS.

Breast cancer (BC) incidence in women produces more than 600,000 deaths each year. The primary cause of death in BC patients is metastasis, whereby cancer cells spread from their primary site of origin and grow in adjacent or distant sites. Distant metastasis produced due to the relapse of the illness is incurable, underscoring the inadequacy of our understanding of its mechanisms. The first step for fighting against disease progression is screening programs for BC focused on image analysis of mammography, MRI and tomosynthesis.

Once the tumour has been diagnosed and given the high variability of clinical progressions, another problem arises: classifying the cancer type and determining the proper treatment for specific cancer. Moreover, in BC, the immune response from the tumour microenvironment has played an essential role in tumour evolution. To evaluate the tumour and its microenvironment, one technique garnered a lot of attention in the last years: Whole Slide Imaging (WSI).

This technique replaces the use of the microscope for classical diagnosis. Still, it has also been used for developing biomarkers that allow the analysis of tumours and classification of cancer subtypes and the study of the immune tumour microenvironment. The use of WSI has applications for predicting the probability of relapse for distant metastasis. Now, for the first time, BosomShield proposes to join the two disciplines (pathological and radiological imaging) in a software that will analyze these images to classify the cancer subtypes and predict (together with the complete clinical history of the patient) the probability of relapse for distant metastasis.

Besides, BosomShield will provide high-level training in BC research to young researchers by offering the necessary transferable skills for thriving careers underpinned using diverse disciplines, digital radiology and pathology, biomedical, AI, privacy and software development.

Topics

Who is involved

OrganisationCityCountryRole
Universitat Rovira I VirgiliTarragonaSpainCoordinator
Hochschule Darmstadt (university of Applied Sciences H-Da)DarmstadtGermanyAssociatedpartner
Mediri GmbHHeidelbergGermanyParticipant
Fundacio Institut D'investigacio Sanitaria Pere Virgili (iispv)TarragonaSpainParticipant
Hospital Universitari Sant Joan De Reus, SamReusSpainAssociatedpartner
Hospital de Tortosa Verge de la CintaTortosaSpainAssociatedpartner
N-Vision Systems and Technologies SLIgualadaSpainParticipant
Servicio Andaluz De SaludSevillaSpainAssociatedpartner
Ummon HealthtechDijonFranceAssociatedpartner
Universite Bourgogne EuropeDijonFranceAssociatedpartner
Universite Marie Et Louis PasteurBesanconFranceParticipant
Azienda Sanitaria Universitaria Friuli CentraleUdineItalyAssociatedpartner
O3 Enterprise SRLTriesteItalyAssociatedpartner
Universita Degli Studi Di UdineUdineItalyParticipant
Institute of Technology Petronas Sdn BhdBandar Seri IskandarMYAssociatedpartner
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsAssociatedpartner
Instytut Biocybernetyki I Inzynierii Biomedycznej Im.macieja Nalecza Polskiej Akademii NaukWarszawaPolandParticipant
Kungliga Tekniska HoegskolanStockholmSwedenParticipant
Lunds UniversitetLundSwedenAssociatedpartner
Sfera It Storitve DooMariborSloveniaAssociatedpartner
Univerza V MariboruMariborSloveniaParticipant
Univerzitetni klinicni center MariborMariborSloveniaAssociatedpartner
General Electric Company dba GE ResearchNiskayunaUnited StatesAssociatedpartner
The University of Texas Health Science Center at HoustonHoustonUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI